ReportsnReports – Endpoints – Clinical Trials in CNS Disorders – Multiple Endpoints and Ratings Scales are Becoming More Widely Adopted
GBI Research, the leading business intelligence provider, has released its latest research “Endpoints- Clinical Trials in Central nervous system Disorders” which provides an insight into different endpoints that are used in central nervous system clinical trials. The report examines different aspects under clinical trial endpoints in central nervous system disorders such as analysis on major marketed Central nervous system drugs with an emphasis on safety and efficacy details, Phase II and Phase III clinical trial analysis for both completed and...
View full press release